Laboratory for Medicinal Chemistry Research, Shionogi & Co., Ltd., Osaka, 561-0825, Japan.
Sustainability Management Department, Shionogi & Co., Ltd., Osaka, 541-0045, Japan.
J Pharm Sci. 2023 Sep;112(9):2516-2523. doi: 10.1016/j.xphs.2023.04.012. Epub 2023 Apr 24.
This study aimed to investigate the crystal forms of an originally designed Y5 receptor antagonist of neuropeptide Y. Polymorphic screening was performed via solvent evaporation and slurry conversion using various solvents. The obtained crystal forms α, β, and γ were characterized by X-ray powder diffraction analysis. Thermal analysis determined that forms α, β, and γ were hemihydrate, metastable and stable forms, respectively; the hemihydrate and the stable forms were candidates. To arrange the particle size, forms α and γ were subjected to jet milling. However, form γ could not be milled because of powder stiction to the apparatus, whereas form α could be. To investigate this mechanism, single-crystal X-ray diffraction analysis was performed. The crystal structure of form γ was characterized by two-dimensional hydrogen bonding between neighboring molecules. This revealed that the functional groups forming hydrogen bonds were exposed on the cleavage plane of form γ. The three-dimensional hydrogen-bonding network with water stabilized the hemihydrate form, α. These results indicate that the hydrogen bondable groups exposed on the cleavage plane of form γ should result in stiction of the powder and adherence to the apparatus. It was concluded that crystal conversion is a method to overcome the milling issue.
本研究旨在探索最初设计的神经肽 Y Y5 受体拮抗剂的晶体形式。通过使用各种溶剂的蒸发溶剂和浆体转化进行多晶筛选。通过 X 射线粉末衍射分析对获得的晶体形式 α、β 和 γ 进行了表征。热分析确定形式 α、β 和 γ 分别为半水合物、亚稳和稳定形式,半水合物和稳定形式是候选形式。为了调节粒径,对形式 α 和 γ 进行了射流粉碎。然而,由于粉末对设备的粘性,形式 γ 无法进行粉碎,而形式 α 可以。为了研究这种机制,进行了单晶 X 射线衍射分析。形式 γ 的晶体结构由相邻分子之间的二维氢键确定。这表明形成氢键的官能团暴露在形式 γ 的解理面上。与水一起稳定半水合物形式 α 的三维氢键网络。这些结果表明,形式 γ 解理面上暴露的氢键基团应导致粉末粘性和对设备的粘附。结论是晶体转化是克服粉碎问题的一种方法。